Establishment and evaluation of an orthotopic transplantation tumor model derived from transgenic mouse with spontaneous pancreatic cancer
10.3969/j.issn.1005-4847.2024.01.001
- VernacularTitle:转基因小鼠源性胰腺癌原位移植瘤模型的构建与评价
- Author:
Qingling AN
1
;
Dengxu TAN
;
Ya ZHAO
;
Caiqin ZHANG
;
Changhong SHI
Author Information
1. 空军军医大学实验动物中心,西安 710032
- Keywords:
pancreatic cancer;
KPC mice;
spontaneous;
orthotopic transplanted tumor
- From:
Acta Laboratorium Animalis Scientia Sinica
2024;32(1):1-8
- CountryChina
- Language:Chinese
-
Abstract:
Objective To establish an orthotopic transplantation tumor model of pancreatic cancer derived from transgenic LSL-KrasG12D/+ LSL-Trp53R172H/+ Pdx1-Cre(KPC)mice.To provide a stable and reliable drug preclinical research animal model to study the developmental mechanism and treatment strategies of pancreatic cancer.Methods Tumor tissue derived from KPC transgenic mice with spontaneous pancreatic cancer was transplanted into the C57BL/6J mouse pancreas.Ultrasound was used to monitor tumor growth.HE and immunofluorescence staining was used to evaluate the pathological characteristics of this model.Results The tumor derived from KPC mice grew steadily on the pancreas of C57BL/6J mice.Tumor cell proliferation index Ki67,matrix fibrosis marker αSMA,and immune cell markers CD45 and CD206 were all stably expressed in the tumor.The model stably retained the pathological features of primary pancreatic cancer.Widespread tumor metastases,which were similar to those observed in patients with pancreatic cancer,developed in this model.Conclusions An orthotopic transplantation model derived from a transgenic mouse with spontaneous pancreatic cancer was established successfully.The model simulates the stromal environment and immune cell infiltration of pancreatic cancer and retains strong stability and uniformity with the original tumor.It can be used as an effective drug preclinical research model to study pancreatic cancer progression and treatment strategies.
